newsfilter
← Latest News
GlobeNewswire·

CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results

-CASGEVY® momentum building; >75 authorized treatment centers (ATCs) activated globally, achieving the target goal and ~115 patients have had cells collected across all regions; positioning the program for strong